Self-questionnaire
OtherQuantitative survey with self-administered questionnaire offered to all patients attending psychiatry study care during the month of the assessment.
NCT Number: NCT05316948
According to the World Health Organization (WHO), "Sexual health is a state of physical, emotional, mental and social well-being in relation to sexuality, not merely the absence of disease, dysfunction or of infirmity. Sexual health requires a positive and respectful approach to sexuality and sexual relationships [...]".
The main objective is to show that a training intervention intended for psychiatric care teams and targeted on the question of the impact of psychiatric disorders and psychotropic drugs on the sexuality of young people, increases the proportion of young people with whom the question of sexual health is discussed (in connection with psychiatric disorders and, if applicable, with the taking of psychotropic treatment, while they are hospitalized for a psychiatric disorder in the clinics of the FSEF and receive, or not, psychotropic treatment ).
Interested in participating?
Request Info15 year and older
All sexes
Observational
Clinique FSEF Vence, Vence, Alpes Maritimes, France
Non-interventional multicenter prospective mixed study (quantitative and qualitative).
Research process in 3 phases:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Quantitative survey with self-administered questionnaire offered to all patients attending psychiatry study care during the month of the assessment.
Time frame: self-questionnaire after the team training (T2 = 1 year)
To show that a training intervention intended for the healthcare team makes it possible to increase the proportion of young people with whom the question of sexual health has been approached, in connection with psychiatric disorders and, if necessary, with taking treatment psychotropics; while they are hospitalized for a psychiatric disorder in the clinics of the FSEF and receive, or not, a psychotropic treatment.
Time frame: self-questionnaire (T0 = within three months of the opening of the center)
Describe the sexuality of adolescents and young adults hospitalized in a psychiatric establishment within the FSEF with quantitative survey with self-questionnaire exploring sexual adverse effects
Time frame: self-questionnaire (T0 = within three months of the opening of the center)
To compare the sexual life of patients hospitalized at the FSEF for a psychiatric illness - according to whether or not they receive psychotropic treatment with quantitative survey with self-questionnaire exploring sexual adverse effects
Time frame: self-questionnaire after the team training (T2 = 1 year)
To compare the perceived impact of psychiatric disorders and psychotropic treatments on patients' sexual satisfaction measured by a Likert scale of sexual satisfaction (rated from 1 to 5 with 1 equal to very satisfied and 5 to very dissatisfied) before and after intervention.
Contact information is provided by the study sponsor or research team.
Anaïs Foussier, IDE
CONTACT
Said SEDFI
CONTACT
Fondation Santé des Étudiants de France
Other
Acronym: SEX-T-ADO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06466356
Behavior, Behavioral Symptoms
Levanger, Trøndelag, Norway
View Trial DetailsNCT06376734
Anxiety Disorders, Behavior
Sunnyvale, California, United States
View Trial DetailsNCT06433583
Behavior, Behavioral Symptoms
Thionville, France
View Trial DetailsNCT07216534
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Columbus, Ohio, United States
View Trial Details